Phieng Siliphaivanh - Concepedia

Author

Phieng Siliphaivanh

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Phieng Siliphaivanh

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Quantitative BioSciences United States Military Academy

About

Phieng Siliphaivanh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	992
2	Natural Sciences	4	4	271
3	Biochemistry	4	4	271
4	Health Sciences	1	1	673
5	Allergy	1	1	10

Phieng Siliphaivanh

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors Erick J. Morris, Sharda Jha, Clifford R. Restaino, Cancer Discovery PharmacotherapyTumor BiologyDrug ResistanceMek InhibitorsReceptor Tyrosine Kinase	2013	673
Total Synthesis of Gypsetin, Deoxybrevianamide E, Brevianamide E, and Tryprostatin B: Novel Constructions of 2,3-Disubstituted Indoles Jeffrey M. Schkeryantz, Jonathan C. G. Woo, Phieng Siliphaivanh, Journal of the American Chemical Society Bioorganic ChemistryPharmaceutical ChemistryDeoxybrevianamide EMedicinal ChemistryBiosynthesis	1999	182
Enantioselective Total Synthesis of (+)-Leucascandrolide A Macrolactone Michael T. Crimmins, Phieng Siliphaivanh Organic Letters	2003	68
Design of novel histone deacetylase inhibitors Phieng Siliphaivanh, Paul E. Harrington, David J. Witter, Bioorganic & Medicinal Chemistry Letters Histone ModificationsChromatinMedicinal ChemistryChromatin RemodelingMedicine	2007	42
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5) R.L. Palte, Sebastian E. Schneider, Michael D. Altman, ACS Medicinal Chemistry Letters	2020	38
Purine derivatives as potent γ-secretase modulators Alexey Rivkin, Sean P. Ahearn, Stephanie M. Chichetti, Bioorganic & Medicinal Chemistry Letters Protein SecretionBiochemistryNatural SciencesPurine DerivativesChemical Biology	2010	35
Identification of Potent Reverse Indazole Inhibitors for HPK1 Elsie C. Yu, Joey L. Methot, Xavier Fradera, ACS Medicinal Chemistry Letters	2021	35
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer Ryan V. Quiroz, Michael H. Reutershan, Sebastian E. Schneider, Journal of Medicinal Chemistry	2021	33
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor Joey L. Methot, Dawn Mampreian Hoffman, David J. Witter, ACS Medicinal Chemistry Letters Histone ModificationsEpigenetic ChangeMolecular BiologyCell CulturePharmacotherapy	2014	31
Discovery of 1-(1<i>H</i>-Pyrazolo[4,3-<i>c</i>]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot, Journal of Medicinal Chemistry Tumor BiologyMedicinal ChemistryUrologyMedicineReceptor Tyrosine Kinase	2016	31

Page 1